TORONTO – Moderna Canada announces the appointment of Roger-Ketcha Ngassam as the Manufacturing Site Head for its mRNA vaccine manufacturing facility. A seasoned leader with local roots and extensive international experience, Roger will oversee the planning, construction, and execution at Moderna’s Good Manufacturing Practice (GMP) site, currently under construction in Laval, Quebec. He will also lead the local team recruitment …